Skip to main content

Table 2 Post-treatment PET-CT results

From: PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy

Post-treatment follow-up PET-CT at 3 months

All patients

n = 73

Residual

n = 9

No residual

n = 64

p-value

Abnormal uptake at primary tumor area, (%)*

   

0.008

 Yes

42 (57.5)

9 (100)

33 (51.6)

 

 No

31 (42.5)

0 (0)

31 (48.4)

 

Mass on primary tumor area, (%)

   

0.103

 Yes

20 (27.4)

5 (55.6)

15 (23.4)

 

 No

53 (72.6)

4 (44.4)

49 (76.6)

 

SUVmax over 4, (%)

   

< 0.001

 Yes

27 (37.0)

9 (100.0)

18 (28.1)

 

 No

46 (63.0)

0 (0)

46 (71.9)

 

SUVmax over 4 and mass on primary tumor area, (%)

   

0.003

 Yes

11 (15.1)

5 (55.6)

6 (9.4)

 

 No

62 (84.9)

4 (44.4)

58 (90.6)

 

Strong symmetric uptake, suggesting muscle activation, (%)

   

0.255

 Yes

8 (11.0)

2 (22.2)

6 (9.4)

 

 No

65 (89.0)

7 (77.8)

58 (90.6)

 
  1. The data is stratified by the presence of residual disease at the primary tumor area (verified by biopsy specimen)
  2. *abnormal uptake is defined as SUVmax over 3.0